{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T21:53:59Z","timestamp":1723067639511},"reference-count":147,"publisher":"Microbiology Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"abstract":"<jats:p>Many acute viral infections can be controlled by vaccination; however, vaccinating against persistent infections remains problematic. Herpesviruses are a classic example. Here, we discuss their immune control, particularly that of gamma-herpesviruses, relating the animal model provided by murid herpesvirus-4 (MuHV-4) to human infections. The following points emerge: (i) CD8<jats:sup>+<\/jats:sup>T-cell evasion by herpesviruses confers a prominent role in host defence on CD4<jats:sup>+<\/jats:sup>T cells. CD4<jats:sup>+<\/jats:sup>T cells inhibit MuHV-4 lytic gene expression via gamma-interferon (IFN-<jats:italic>\u03b3<\/jats:italic>). By reducing the lytic secretion of immune evasion proteins, they may also help CD8<jats:sup>+<\/jats:sup>T cells to control virus-driven lymphoproliferation in mixed lytic\/latent lesions. Similarly, CD4<jats:sup>+<\/jats:sup>T cells specific for Epstein\u2013Barr virus lytic antigens could improve the impact of adoptively transferred, latent antigen-specific CD8<jats:sup>+<\/jats:sup>T cells. (ii) In general, viral immune evasion necessitates multiple host effectors for optimal control. Thus, subunit vaccines, which tend to prime single effectors, have proved less successful than attenuated virus mutants, which prime multiple effectors. Latency-deficient mutants could make safe and effective gamma-herpesvirus vaccines. (iii) The antibody response to MuHV-4 infection helps to prevent disease but is suboptimal for neutralization. Vaccinating virus carriers with virion fusion complex components improves their neutralization titres. Reducing the infectivity of herpesvirus carriers in this way could be a useful adjunct to vaccinating naive individuals with attenuated mutants.<\/jats:p>","DOI":"10.1099\/vir.0.013300-0","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T18:36:17Z","timestamp":1252953377000},"page":"2317-2330","source":"Crossref","is-referenced-by-count":42,"title":["Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4"],"prefix":"10.1099","volume":"90","author":[{"given":"P. G.","family":"Stevenson","sequence":"first","affiliation":[{"name":"Division of Virology, Department of Pathology, University of Cambridge, UK"}]},{"given":"J. P.","family":"Simas","sequence":"additional","affiliation":[{"name":"Instituto de Microbiologia e Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal"}]},{"given":"S.","family":"Efstathiou","sequence":"additional","affiliation":[{"name":"Division of Virology, Department of Pathology, University of Cambridge, UK"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein\u2013Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"R2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.190.4.567","article-title":"Epstein\u2013Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients","volume":"190","author":"Babcock","year":"1999","journal-title":"J Exp Med"},{"key":"R3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vetimm.2006.03.014","article-title":"Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection","volume":"112","author":"Baigent","year":"2006","journal-title":"Vet Immunol Immunopathol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1128\/JVI.68.7.4700-4704.1994","article-title":"Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice","volume":"68","author":"Battegay","year":"1994","journal-title":"J Virol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.040575197","article-title":"Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice","volume":"97","author":"Belz","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1099\/vir.0.18821-0","article-title":"Absence of a functional defect in CD8+ T cells during primary murine gammaherpesvirus-68 infection of I-Ab\u2212\/\u2212 mice","volume":"84","author":"Belz","year":"2003","journal-title":"J Gen Virol"},{"key":"R7","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pbio.0030120","article-title":"Gamma-herpesvirus latency requires T cell evasion during episome maintenance","volume":"3","author":"Bennett","year":"2005","journal-title":"PLoS Biol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1098\/rstb.1997.0181","article-title":"Marek's disease herpesvirus: oncogenesis and prevention","volume":"352","author":"Biggs","year":"1997","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R9","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"Blake","year":"2000","journal-title":"J Immunol"},{"key":"R10","first-page":"468","article-title":"Isolation of five strains of herpesviruses from two species of free living small rodents","volume":"24","author":"Blaskovic","year":"1980","journal-title":"Acta Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1074-7613(01)00213-8","article-title":"MHC class I ubiquitination by a viral PHD\/LAP finger protein","volume":"15","author":"Boname","year":"2001","journal-title":"Immunity"},{"key":"R12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1074-7613(04)00047-0","article-title":"Viral degradation of the MHC class I peptide loading complex","volume":"20","author":"Boname","year":"2004a","journal-title":"Immunity"},{"key":"R13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/vir.0.19592-0","article-title":"Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant","volume":"85","author":"Boname","year":"2004b","journal-title":"J Gen Virol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biologicals.2005.08.011","article-title":"Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials","volume":"33","author":"Bouma","year":"2005","journal-title":"Biologicals"},{"key":"R15","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1099\/0022-1317-78-7-1675","article-title":"Murine gammaherpesvirus 68 encodes tRNA-like sequences which are expressed during latency","volume":"78","author":"Bowden","year":"1997","journal-title":"J Gen Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1371\/journal.ppat.0020037","article-title":"Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells","volume":"2","author":"Braaten","year":"2006","journal-title":"PLoS Pathog"},{"key":"R17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1084\/jem.194.3.301","article-title":"A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load","volume":"194","author":"Bridgeman","year":"2001","journal-title":"J Exp Med"},{"key":"R18","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1128\/JVI.66.8.5161-5167.1992","article-title":"An Epstein\u2013Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases","volume":"66","author":"Burkhardt","year":"1992","journal-title":"J Virol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","article-title":"Large clonal expansions of CD8+ T cells in acute infectious mononucleosis","volume":"2","author":"Callan","year":"1996","journal-title":"Nat Med"},{"key":"R20","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.184.3.863","article-title":"Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells","volume":"184","author":"Cardin","year":"1996","journal-title":"J Exp Med"},{"key":"R21","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1128\/IAI.00787-06","article-title":"Immunity to microbes: lessons from primary immunodeficiencies","volume":"75","author":"Carneiro-Sampaio","year":"2007","journal-title":"Infect Immun"},{"key":"R22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.smim.2006.07.006","article-title":"Description of HLA class I- and CD8-deficient patients: insights into the function of cytotoxic T lymphocytes and NK cells in host defense","volume":"18","author":"Cerundolo","year":"2006","journal-title":"Semin Immunol"},{"key":"R23","first-page":"309","article-title":"A herpesvirus from an European shrew ( Crocidura russula )","volume":"38","author":"Chastel","year":"1994","journal-title":"Acta Virol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1073\/pnas.96.9.5135","article-title":"CD4+ T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN- \u03b3","volume":"96","author":"Christensen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25","doi-asserted-by":"crossref","first-page":"13093","DOI":"10.1128\/JVI.77.24.13093-13105.2003","article-title":"An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame","volume":"77","author":"Coleman","year":"2003a","journal-title":"J Virol"},{"key":"R26","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1128\/JVI.77.4.2410-2417.2003","article-title":"Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency","volume":"77","author":"Coleman","year":"2003b","journal-title":"J Virol"},{"key":"R27","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.73.4.3154-3161.1999","article-title":"Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein\u2013Barr virus type I latency","volume":"73","author":"Davenport","year":"1999","journal-title":"J Virol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/JVI.78.10.5103-5112.2004","article-title":"Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo","volume":"78","author":"de Lima","year":"2004","journal-title":"J Virol"},{"key":"R29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1099\/vir.0.80480-0","article-title":"Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo","volume":"86","author":"de Lima","year":"2005","journal-title":"J Gen Virol"},{"key":"R30","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/JVI.71.6.4278-4283.1997","article-title":"Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells","volume":"71","author":"Dutia","year":"1997","journal-title":"J Virol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1128\/JVI.67.9.5247-5252.1993","article-title":"Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells","volume":"67","author":"Ehtisham","year":"1993","journal-title":"J Virol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J Virol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt's lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"R34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0966-842X(00)01742-X","article-title":"The ins and outs of EBV infection","volume":"8","author":"Faulkner","year":"2000","journal-title":"Trends Microbiol"},{"key":"R35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1099\/vir.0.19760-0","article-title":"Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73","volume":"85","author":"Fowler","year":"2004","journal-title":"J Gen Virol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1099\/vir.0.19594-0","article-title":"ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency","volume":"84","author":"Fowler","year":"2003","journal-title":"J Gen Virol"},{"key":"R37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-1702(02)00120-X","article-title":"Immune evasion by a novel family of viral PHD\/LAP-finger proteins of gamma-2 herpesviruses and poxviruses","volume":"88","author":"Fr\u00fch","year":"2002","journal-title":"Virus Res"},{"key":"R38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1172\/JCI22053","article-title":"Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo","volume":"114","author":"Fu","year":"2004","journal-title":"J Clin Invest"},{"key":"R39","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1128\/JVI.76.22.11460-11468.2002","article-title":"Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice","volume":"76","author":"Gangappa","year":"2002","journal-title":"J Virol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/vir.0.81760-0","article-title":"Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies","volume":"87","author":"Gill","year":"2006","journal-title":"J Gen Virol"},{"key":"R41","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1099\/vir.0.010603-0","article-title":"Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization","volume":"90","author":"Gill","year":"2009","journal-title":"J Gen Virol"},{"key":"R42","doi-asserted-by":"crossref","first-page":"13082","DOI":"10.1128\/JVI.01141-07","article-title":"Evidence for a multiprotein gamma-2 herpesvirus entry complex","volume":"81","author":"Gillet","year":"2007a","journal-title":"J Virol"},{"key":"R43","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1038\/sj.emboj.7601925","article-title":"Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B","volume":"26","author":"Gillet","year":"2007b","journal-title":"EMBO J"},{"key":"R44","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1099\/vir.0.82313-0","article-title":"Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice","volume":"87","author":"Gillet","year":"2006","journal-title":"J Gen Virol"},{"key":"R45","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1371\/journal.pone.0000899","article-title":"Post-exposure vaccination improves gammaherpesvirus neutralization","volume":"2","author":"Gillet","year":"2007a","journal-title":"PLoS One"},{"key":"R46","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1371\/journal.pone.0000705","article-title":"The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization","volume":"2","author":"Gillet","year":"2007b","journal-title":"PLoS One"},{"key":"R47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1099\/vir.0.83519-0","article-title":"Glycoprotein B switches conformation during murid herpesvirus 4 entry","volume":"89","author":"Gillet","year":"2008a","journal-title":"J Gen Virol"},{"key":"R48","doi-asserted-by":"crossref","first-page":"e2811","DOI":"10.1371\/journal.pone.0002811","article-title":"The murid herpesvirus-4 gL regulates an entry-associated conformation change in gH","volume":"3","author":"Gillet","year":"2008b","journal-title":"PLoS One"},{"key":"R49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1099\/vir.0.005785-0","article-title":"In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection","volume":"90","author":"Gillet","year":"2009a","journal-title":"J Gen Virol"},{"key":"R50","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1099\/vir.0.008755-0","article-title":"Glycoprotein L sets the neutralization profile of murid herpesvirus-4","volume":"90","author":"Gillet","year":"2009b","journal-title":"J Gen Virol"},{"key":"R51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.56.082103.104727","article-title":"Post-transplant lymphoproliferative disorders","volume":"56","author":"Gottschalk","year":"2005","journal-title":"Annu Rev Med"},{"key":"R52","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"key":"R53","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"key":"R54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1348-0421.1982.tb00203.x","article-title":"Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody","volume":"26","author":"Hayashida","year":"1982","journal-title":"Microbiol Immunol"},{"key":"R55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0966-842X(98)01255-4","article-title":"Immune evasion by cytomegalovirus \u2013 survival strategies of a highly adapted opportunist","volume":"6","author":"Hengel","year":"1998","journal-title":"Trends Microbiol"},{"key":"R56","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1128\/JVI.74.17.7861-7868.2000","article-title":"Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus","volume":"74","author":"Hengel","year":"2000","journal-title":"J Virol"},{"key":"R57","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1084\/jem.20070256","article-title":"A CD8+ T cell immune evasion protein specific to Epstein\u2013Barr virus and its close relatives in Old World primates","volume":"204","author":"Hislop","year":"2007","journal-title":"J Exp Med"},{"key":"R58","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2105\/AJPH.54.10.1699","article-title":"The incubation period of infectious mononucleosis","volume":"54","author":"Hoagland","year":"1964","journal-title":"Am J Public Health Nations Health"},{"key":"R59","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1073\/pnas.96.13.7508","article-title":"Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8+ T lymphocytes","volume":"96","author":"Husain","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R60","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1128\/JVI.74.21.10142-10152.2000","article-title":"Infectious Epstein\u2013Barr virus lacking major glycoprotein BLLF1 (gp350\/220) demonstrates the existence of additional viral ligands","volume":"74","author":"Janz","year":"2000","journal-title":"J Virol"},{"key":"R61","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1128\/JVI.01159-08","article-title":"Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords","volume":"82","author":"Johnson","year":"2008","journal-title":"J Virol"},{"key":"R62","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.4049\/jimmunol.170.4.2022","article-title":"Memory inflation: continuous accumulation of antiviral CD8+ T cells over time","volume":"170","author":"Karrer","year":"2003","journal-title":"J Immunol"},{"key":"R63","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.4049\/jimmunol.179.12.8392","article-title":"A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity","volume":"179","author":"Kayhan","year":"2007","journal-title":"J Immunol"},{"key":"R64","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.4049\/jimmunol.169.4.1984","article-title":"Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals","volume":"169","author":"Khan","year":"2002","journal-title":"J Immunol"},{"key":"R65","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.4049\/jimmunol.168.8.3958","article-title":"Antibody-mediated control of persistent gamma-herpesvirus infection","volume":"168","author":"Kim","year":"2002","journal-title":"J Immunol"},{"key":"R66","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0002-9343(82)90079-1","article-title":"Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds","volume":"73","author":"Klein","year":"1982","journal-title":"Am J Med"},{"key":"R67","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1164164","article-title":"Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency","volume":"322","author":"Knickelbein","year":"2008","journal-title":"Science"},{"key":"R68","first-page":"101","article-title":"Further isolation of murine herpesviruses from small mammals in southwestern Slovakia","volume":"37","author":"Kozuch","year":"1993","journal-title":"Acta Virol"},{"key":"R69","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/MCB.18.9.5219","article-title":"Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus","volume":"18","author":"Lee","year":"1998","journal-title":"Mol Cell Biol"},{"key":"R70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature"},{"key":"R71","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1128\/JVI.73.12.9849-9857.1999","article-title":"T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice","volume":"73","author":"Liu","year":"1999","journal-title":"J Virol"},{"key":"R72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(02)00509-5","article-title":"Virus subversion of the MHC class I peptide-loading complex","volume":"18","author":"Lybarger","year":"2003","journal-title":"Immunity"},{"key":"R73","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1128\/JVI.77.13.7308-7318.2003","article-title":"Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes","volume":"77","author":"Marques","year":"2003","journal-title":"J Virol"},{"key":"R74","doi-asserted-by":"crossref","first-page":"e1000177","DOI":"10.1371\/journal.ppat.1000177","article-title":"A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus","volume":"4","author":"Marques","year":"2008","journal-title":"PLoS Pathog"},{"key":"R75","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.200324794","article-title":"Epstein\u2013Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells","volume":"34","author":"Mautner","year":"2004","journal-title":"Eur J Immunol"},{"key":"R76","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1128\/JVI.78.13.6836-6845.2004","article-title":"Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency","volume":"78","author":"McClellan","year":"2004","journal-title":"J Virol"},{"key":"R77","first-page":"58","article-title":"Immunity to homologous grafted skin: the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br J Exp Pathol"},{"key":"R78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1099\/vir.0.006569-0","article-title":"In vivo imaging of murid herpesvirus-4 infection","volume":"90","author":"Milho","year":"2009","journal-title":"J Gen Virol"},{"key":"R79","doi-asserted-by":"crossref","first-page":"10295","DOI":"10.1128\/JVI.77.19.10295-10303.2003","article-title":"The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency","volume":"77","author":"Moorman","year":"2003","journal-title":"J Virol"},{"key":"R80","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/JVI.80.3.1592-1598.2006","article-title":"A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge","volume":"80","author":"Moser","year":"2006","journal-title":"J Virol"},{"key":"R81","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1098\/rstb.2000.0779","article-title":"Natural history of murine gamma-herpesvirus infection","volume":"356","author":"Nash","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R82","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/jir.2005.25.373","article-title":"Human gammaherpesvirus cytokines and chemokine receptors","volume":"25","author":"Nicholas","year":"2005","journal-title":"J Interferon Cytokine Res"},{"key":"R83","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1128\/JVI.77.22.12088-12104.2003","article-title":"Cytolytic CD4+-T-cell clones reactive to EBNA1 inhibit Epstein\u2013Barr virus-induced B-cell proliferation","volume":"77","author":"Nikiforow","year":"2003","journal-title":"J Virol"},{"key":"R84","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.chom.2007.06.013","article-title":"CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class I","volume":"2","author":"Orr","year":"2007","journal-title":"Cell Host Microbe"},{"key":"R85","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1084\/jem.191.3.573","article-title":"A broad spectrum secreted chemokine binding protein encoded by a herpesvirus","volume":"191","author":"Parry","year":"2000","journal-title":"J Exp Med"},{"key":"R86","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/0022-1317-77-2-217","article-title":"Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo","volume":"77","author":"Poli\u0107","year":"1996","journal-title":"J Gen Virol"},{"key":"R87","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.188.6.1047","article-title":"Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection","volume":"188","author":"Poli\u0107","year":"1998","journal-title":"J Exp Med"},{"key":"R88","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1099\/vir.0.2008\/005066-0","article-title":"A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones","volume":"89","author":"Proen\u00e7a","year":"2008","journal-title":"J Gen Virol"},{"key":"R89","first-page":"315","article-title":"Murine model of cytomegalovirus latency and reactivation","volume":"325","author":"Reddehase","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"R90","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0002-9440(10)62507-2","article-title":"In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection","volume":"159","author":"Redwine","year":"2001","journal-title":"Am J Pathol"},{"key":"R91","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1002\/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J","article-title":"A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope","volume":"32","author":"Rice","year":"2002","journal-title":"Eur J Immunol"},{"key":"R92","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein\u2013Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R93","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1128\/JVI.02700-05","article-title":"Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes","volume":"80","author":"Rodrigues","year":"2006","journal-title":"J Virol"},{"key":"R94","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1371\/journal.pone.0000560","article-title":"IgG Fc receptors provide an alternative infection route for murine gamma-herpesvirus-68","volume":"2","author":"Rosa","year":"2007","journal-title":"PLoS One"},{"key":"R95","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/JVI.02609-08","article-title":"The intersection of Epstein\u2013Barr virus with the germinal center","volume":"83","author":"Roughan","year":"2009","journal-title":"J Virol"},{"key":"R96","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.66.8.4654-4661.1992","article-title":"The Epstein\u2013Barr virus nuclear protein 1 promoter active in type I latency is autoregulated","volume":"66","author":"Sample","year":"1992","journal-title":"J Virol"},{"key":"R97","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1128\/JVI.71.5.3916-3921.1997","article-title":"Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68","volume":"71","author":"Sarawar","year":"1997","journal-title":"J Virol"},{"key":"R98","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.0510512103","article-title":"Resting B cells as a transfer vehicle for Epstein\u2013Barr virus infection of epithelial cells","volume":"103","author":"Shannon-Lowe","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R99","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.175.5.1337","article-title":"Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons","volume":"175","author":"Simmons","year":"1992","journal-title":"J Exp Med"},{"key":"R100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"R101","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/eji.200636164","article-title":"CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo","volume":"36","author":"Smith","year":"2006","journal-title":"Eur J Immunol"},{"key":"R102","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1371\/journal.pone.0001048","article-title":"Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells","volume":"2","author":"Smith","year":"2007","journal-title":"PLoS One"},{"key":"R103","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J Infect Dis"},{"key":"R104","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1128\/JVI.78.13.6827-6835.2004","article-title":"An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection","volume":"78","author":"Sparks-Thissen","year":"2004","journal-title":"J Virol"},{"key":"R105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.virol.2005.05.011","article-title":"CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFN gamma","volume":"338","author":"Sparks-Thissen","year":"2005","journal-title":"Virology"},{"key":"R106","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1128\/JVI.77.7.4306-4314.2003","article-title":"Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes","volume":"77","author":"Stebbing","year":"2003","journal-title":"J Virol"},{"key":"R107","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1128\/JVI.00108-07","article-title":"Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner","volume":"81","author":"Steed","year":"2007","journal-title":"J Virol"},{"key":"R108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.coi.2004.05.002","article-title":"Immune evasion by gamma-herpesviruses","volume":"16","author":"Stevenson","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"R109","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/vim.2005.18.445","article-title":"Immune mechanisms in murine gammaherpesvirus-68 infection","volume":"18","author":"Stevenson","year":"2005","journal-title":"Viral Immunol"},{"key":"R110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/JVI.71.1.145-151.1997","article-title":"The immunogenicity of intracerebral virus infection depends on anatomical site","volume":"71","author":"Stevenson","year":"1997a","journal-title":"J Virol"},{"key":"R111","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/eji.1830271225","article-title":"Recruitment, activation and proliferation of CD8+ memory T cells in an immunoprivileged site","volume":"27","author":"Stevenson","year":"1997b","journal-title":"Eur J Immunol"},{"key":"R112","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.95.26.15565","article-title":"Virus-specific CD8+ T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice","volume":"95","author":"Stevenson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1099\/0022-1317-80-2-477","article-title":"Immunological control of a murine gammaherpesvirus independent of CD8+ T cells","volume":"80","author":"Stevenson","year":"1999a","journal-title":"J Gen Virol"},{"key":"R114","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L","article-title":"Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection","volume":"29","author":"Stevenson","year":"1999b","journal-title":"Eur J Immunol"},{"key":"R115","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1073\/pnas.96.16.9281","article-title":"A gamma-herpesvirus sneaks through a CD8+ T cell response primed to a lytic-phase epitope","volume":"96","author":"Stevenson","year":"1999c","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R116","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ni818","article-title":"K3-mediated evasion of CD8+ T cells aids amplification of a latent gamma-herpesvirus","volume":"3","author":"Stevenson","year":"2002","journal-title":"Nat Immunol"},{"key":"R117","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0264-410X(98)00190-X","article-title":"Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination","volume":"17","author":"Stewart","year":"1999","journal-title":"Vaccine"},{"key":"R118","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1128\/JVI.01055-07","article-title":"Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein\u2013Barr virus BZLF1 promoter","volume":"81","author":"Sun","year":"2007","journal-title":"J Virol"},{"key":"R119","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128072-200103040-00005","article-title":"25\u2005years' experience with the Biken Oka strain varicella vaccine: a clinical overview","volume":"3","author":"Takahashi","year":"2001","journal-title":"Paediatr Drugs"},{"key":"R120","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1128\/JVI.79.23.14668-14679.2005","article-title":"Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB \u03b2 2 microglobulin-deficient mice","volume":"79","author":"Tarakanova","year":"2005","journal-title":"J Virol"},{"key":"R121","doi-asserted-by":"crossref","first-page":"e1000352","DOI":"10.1371\/journal.ppat.1000352","article-title":"De novo synthesis of VP16 coordinates the exit from HSV latency in vivo","volume":"5","author":"Thompson","year":"2009","journal-title":"PLoS Pathog"},{"key":"R122","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.4049\/jimmunol.157.7.3074","article-title":"Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice","volume":"157","author":"Thomsen","year":"1996","journal-title":"J Immunol"},{"key":"R123","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein\u2013Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"R124","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1073\/pnas.77.9.5307","article-title":"Monoclonal antibodies against the major glycoprotein (gp350\/220) of Epstein\u2013Barr virus neutralize infectivity","volume":"77","author":"Thorley-Lawson","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R125","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1128\/JVI.76.14.7125-7132.2002","article-title":"Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus","volume":"76","author":"Tibbetts","year":"2002","journal-title":"J Virol"},{"key":"R126","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1128\/JVI.77.4.2522-2529.2003","article-title":"Effective vaccination against long-term gammaherpesvirus latency","volume":"77","author":"Tibbetts","year":"2003","journal-title":"J Virol"},{"key":"R127","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2006.05.020","article-title":"A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells","volume":"353","author":"Tibbetts","year":"2006","journal-title":"Virology"},{"key":"R128","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1128\/JVI.72.3.2560-2563.1998","article-title":"Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP","volume":"72","author":"Tomazin","year":"1998","journal-title":"J Virol"},{"key":"R129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/JVI.72.1.882-885.1998","article-title":"Clearance of an influenza A virus by CD4+ T cells is inefficient in the absence of B cells","volume":"72","author":"Topham","year":"1998","journal-title":"J Virol"},{"key":"R130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.72.1.873-875.1998","article-title":"Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system","volume":"72","author":"Turner","year":"1998","journal-title":"J Virol"},{"key":"R131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1099\/0022-1317-77-4-627","article-title":"Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells","volume":"77","author":"Usherwood","year":"1996","journal-title":"J Gen Virol"},{"key":"R132","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1128\/JVI.75.17.8283-8288.2001","article-title":"Latent antigen vaccination in a model gammaherpesvirus infection","volume":"75","author":"Usherwood","year":"2001","journal-title":"J Virol"},{"key":"R133","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/eji.200526245","article-title":"Control of murine gammaherpesvirus infection is independent of NK cells","volume":"35","author":"Usherwood","year":"2005","journal-title":"Eur J Immunol"},{"key":"R134","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1128\/JVI.74.15.6741-6747.2000","article-title":"Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action","volume":"74","author":"van Berkel","year":"2000","journal-title":"J Virol"},{"key":"R135","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1073\/pnas.0610847104","article-title":"Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia","volume":"104","author":"Verjans","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R136","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0952-7915(99)80063-6","article-title":"Unravelling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection","volume":"11","author":"Virgin","year":"1999","journal-title":"Curr Opin Immunol"},{"key":"R137","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1128\/JVI.71.8.5894-5904.1997","article-title":"Complete sequence and genomic analysis of murine gammaherpesvirus 68","volume":"71","author":"Virgin","year":"1997","journal-title":"J Virol"},{"key":"R138","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.20031219","article-title":"Evidence for the presentation of major histocompatibility complex class I-restricted Epstein\u2013Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes","volume":"199","author":"Voo","year":"2004","journal-title":"J Exp Med"},{"key":"R139","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1128\/JVI.73.9.7619-7626.1999","article-title":"The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL\/6 mice is almost entirely directed against a single immunodominant determinant","volume":"73","author":"Wallace","year":"1999","journal-title":"J Virol"},{"key":"R140","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm1297-1346","article-title":"Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease","volume":"3","author":"Weck","year":"1997","journal-title":"Nat Med"},{"key":"R141","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1128\/JVI.01663-07","article-title":"X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency","volume":"81","author":"Wilson","year":"2007","journal-title":"J Virol"},{"key":"R142","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijc.2910430114","article-title":"The Epstein\u2013Barr virus: host balance in acute infectious mononucleosis patients receiving acyclovir anti-viral therapy","volume":"43","author":"Yao","year":"1989a","journal-title":"Int J Cancer"},{"key":"R143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.2910430115","article-title":"Epstein\u2013Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers","volume":"43","author":"Yao","year":"1989b","journal-title":"Int J Cancer"},{"key":"R144","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ni1102-1019","article-title":"Viral interference with antigen presentation","volume":"3","author":"Yewdell","year":"2002","journal-title":"Nat Immunol"},{"key":"R145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-inhibition of synthesis and antigen presentation by Epstein\u2013Barr virus-encoded EBNA1","volume":"301","author":"Yin","year":"2003","journal-title":"Science"},{"key":"R146","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0092-8674(94)90215-1","article-title":"A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes","volume":"77","author":"York","year":"1994","journal-title":"Cell"},{"key":"R147","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","article-title":"Protective \u2018immunity\u2019 by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called \u2018immunological memory\u2019","volume":"211","author":"Zinkernagel","year":"2006","journal-title":"Immunol Rev"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.013300-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T19:11:00Z","timestamp":1685128260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.013300-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":147,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.013300-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}